CORRESP Filing
Jaguar Health, Inc.
Date: Nov. 24, 2025 · CIK: 0001585608 · Accession: 0001193125-25-293735
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290702
Letter
November 24, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Health, Inc. Registration Statement on Form S-3 File No. 333-290702 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “ Registrant ”), hereby requests the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) be declared effective by the Securities and Exchange Commission on Tuesday, November 25, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration. Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358. Very truly yours, Jaguar Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. • 200 Pine Street, Suite 400 • San Francisco, CA 94104 Tel : +1 (415) 371-8300 • Fax: +1 (415) 371-8311 • https://jaguar.health
Show Raw Text
CORRESP 1 filename1.htm CORRESP November 24, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Health, Inc. Registration Statement on Form S-3 File No. 333-290702 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Jaguar Health, Inc., a Delaware corporation (the “ Registrant ”), hereby requests the above-referenced Registration Statement on Form S-3 (the “ Registration Statement ”) be declared effective by the Securities and Exchange Commission on Tuesday, November 25, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes each of Donald C. Reinke, Esq. and Michael S. Lee, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration. Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358. Very truly yours, Jaguar Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. • 200 Pine Street, Suite 400 • San Francisco, CA 94104 Tel : +1 (415) 371-8300 • Fax: +1 (415) 371-8311 • https://jaguar.health